Response to 'Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable'. | Br J Dermatol;187(6): 1058-1059, 2022 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Response to 'Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable'.

Faries, Mark B; Cochran, Alistair J; Thompson, John F.

Affiliation

Faries MB; The Angeles Clinic and Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Cochran AJ; University of California, Los Angeles, CA, USA.
Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.

Br J Dermatol ; 187(6): 1058-1059, 2022 12.

Article in En | MEDLINE | ID: mdl-35988015

Subject(s)

Lymph Node Excision; Humans; Lymphatic Metastasis

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymph Node Excision Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Dermatol Year: 2022 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymph Node Excision Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Dermatol Year: 2022 Type: Article Affiliation country: United States